130 related articles for article (PubMed ID: 24941992)
21. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.
Takahashi M; Yang XJ; Sugimura J; Backdahl J; Tretiakova M; Qian CN; Gray SG; Knapp R; Anema J; Kahnoski R; Nicol D; Vogelzang NJ; Furge KA; Kanayama H; Kagawa S; Teh BT
Oncogene; 2003 Oct; 22(43):6810-8. PubMed ID: 14555994
[TBL] [Abstract][Full Text] [Related]
22. Fine-needle aspiration of metastatic clear cell carcinoma of the kidney: employment of microdissection and the polymerase chain reaction as a potential diagnostic tool.
Beaty MW; Zhuang Z; Park WS; Emmert-Buck MR; Linehan WM; Lubensky IA; Abati A
Cancer; 1997 Jun; 81(3):180-6. PubMed ID: 9196017
[TBL] [Abstract][Full Text] [Related]
23. Important surgical considerations in the management of renal cell carcinoma (RCC) with inferior vena cava (IVC) tumour thrombus.
Lawindy SM; Kurian T; Kim T; Mangar D; Armstrong PA; Alsina AE; Sheffield C; Sexton WJ; Spiess PE
BJU Int; 2012 Oct; 110(7):926-39. PubMed ID: 22540179
[TBL] [Abstract][Full Text] [Related]
24. The expanding role of imaging in the management of renal cell carcinoma.
Murphy G; Jhaveri K
Expert Rev Anticancer Ther; 2011 Dec; 11(12):1871-88. PubMed ID: 22117155
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical analysis of kallikrein-related peptidases in the normal kidney and renal tumors: potential clinical implications.
Gabril M; White NM; Moussa M; Chow TF; Metias SM; Fatoohi E; Yousef GM
Biol Chem; 2010 Apr; 391(4):403-9. PubMed ID: 20128686
[TBL] [Abstract][Full Text] [Related]
26. Renal Cell Carcinoma Presenting as Carcinoma of Unknown Primary Site: Recognition of a Treatable Patient Subset.
Greco FA; Hainsworth JD
Clin Genitourin Cancer; 2018 Aug; 16(4):e893-e898. PubMed ID: 29610002
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
Klatte T; Seligson DB; Riggs SB; Leppert JT; Berkman MK; Kleid MD; Yu H; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Clin Cancer Res; 2007 Dec; 13(24):7388-93. PubMed ID: 18094421
[TBL] [Abstract][Full Text] [Related]
28. Molecular differential diagnosis of renal carcinoma: from microscopes to microsatellites.
Steiner G; Sidransky D
Am J Pathol; 1996 Dec; 149(6):1791-5. PubMed ID: 8952515
[TBL] [Abstract][Full Text] [Related]
29. Altered expression of beta-catenin in renal cell cancer and transitional cell cancer with the absence of beta-catenin gene mutations.
Bilim V; Kawasaki T; Katagiri A; Wakatsuki S; Takahashi K; Tomita Y
Clin Cancer Res; 2000 Feb; 6(2):460-6. PubMed ID: 10690524
[TBL] [Abstract][Full Text] [Related]
30. Genitourinary imaging: part 2, role of imaging in medical management of advanced renal cell carcinoma.
Shinagare AB; Krajewski KM; Jagannathan JP; Ramaiya NH
AJR Am J Roentgenol; 2012 Nov; 199(5):W554-64. PubMed ID: 23096199
[TBL] [Abstract][Full Text] [Related]
31. Expression of hypoxia inducible factor-1α and 2α in conventional renal cell carcinoma with or without sarcomatoid differentiation.
Ku JH; Park YH; Myung JK; Moon KC; Kwak C; Kim HH
Urol Oncol; 2011; 29(6):731-7. PubMed ID: 19914104
[TBL] [Abstract][Full Text] [Related]
32. Renal epithelial neoplasms: diagnostic applications of gene expression profiling.
Young AN; Master VA; Paner GP; Wang MD; Amin MB
Adv Anat Pathol; 2008 Jan; 15(1):28-38. PubMed ID: 18156810
[TBL] [Abstract][Full Text] [Related]
33. [Possibilities of molecular diagnosis of renal cell carcinoma].
Junker K
Aktuelle Urol; 2014 Sep; 45(5):370-3. PubMed ID: 25230022
[TBL] [Abstract][Full Text] [Related]
34. Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma.
Breault JE; Shiina H; Igawa M; Ribeiro-Filho LA; Deguchi M; Enokida H; Urakami S; Terashima M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):557-64. PubMed ID: 15701841
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia-inducible factor 1alpha expression in renal cell carcinoma analyzed by tissue microarray.
Lidgren A; Hedberg Y; Grankvist K; Rasmuson T; Bergh A; Ljungberg B
Eur Urol; 2006 Dec; 50(6):1272-7. PubMed ID: 16814458
[TBL] [Abstract][Full Text] [Related]
36. Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray.
Abrahams NA; MacLennan GT; Khoury JD; Ormsby AH; Tamboli P; Doglioni C; Schumacher B; Tickoo SK
Histopathology; 2004 Dec; 45(6):593-602. PubMed ID: 15569050
[TBL] [Abstract][Full Text] [Related]
37. Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma.
Thompson RH; Gillett MD; Cheville JC; Lohse CM; Dong H; Webster WS; Chen L; Zincke H; Blute ML; Leibovich BC; Kwon ED
Cancer; 2005 Nov; 104(10):2084-91. PubMed ID: 16208700
[TBL] [Abstract][Full Text] [Related]
38. Correlation of genomic alterations assessed by next-generation sequencing (NGS) of tumor tissue DNA and circulating tumor DNA (ctDNA) in metastatic renal cell carcinoma (mRCC): potential clinical implications.
Hahn AW; Gill DM; Maughan B; Agarwal A; Arjyal L; Gupta S; Streeter J; Bailey E; Pal SK; Agarwal N
Oncotarget; 2017 May; 8(20):33614-33620. PubMed ID: 28431395
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic and prognostic potential of circulating cell-free genomic and mitochondrial DNA fragments in clear cell renal cell carcinoma patients.
Lu H; Busch J; Jung M; Rabenhorst S; Ralla B; Kilic E; Mergemeier S; Budach N; Fendler A; Jung K
Clin Chim Acta; 2016 Jan; 452():109-19. PubMed ID: 26569345
[TBL] [Abstract][Full Text] [Related]
40. Classical pathology versus molecular pathology in renal cell carcinoma.
Soung Sullivan P; Rao J; Cheng L; Cote RJ
Curr Urol Rep; 2007 Jan; 8(1):5-11. PubMed ID: 17239311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
